2023 annual financial data
BioMarin Pharmaceutical 2023 Revenue growth
Direct answer
Revenue growth was 15.42%.
Operating income was 185,774,000 USD and net income was 167,645,000 USD.
Operating cash flow was 159,259,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,419,226,000 USD
- Operating income
- 185,774,000 USD
- Net income
- 167,645,000 USD
- Operating cash flow
- 159,259,000 USD